MedicineDermatologyPharmacotherapyDermatopathologyImmunopathologyInflammationInflammatory DermatosesInflammatory LesionsInflammatory Skin DiseasesInflammatory Skin DisordersNecrosisSkin InfectionsCellulitis TreatmentCutaneous NecrosisPsoriasiform DermatitisPsoriatic DiseaseScalp InfectionScalp WoundsTumor Necrosis Factor Inhibitor TherapyTumor Necrosis Factor Therapy
The authors present the case of a 30-year-old male patient with a severe and long-standing dissecting cellulitis of the scalp. The disease did not respond to conventional treatment, including oral antibiotics, isotretinoin, and prednisolone. Quality of life was significantly impaired. After introduction of anti-tumor necrosis factor-alpha treatment (infliximab), the malodorous discharge stopped, inflammation was reduced significantly, nodules became flat, and pain decreased. The treatment was well tolerated although he developed a temporary psoriasiform rash after the second intravenous infusion. In conclusion, anti-tumor necrosis factor-alpha treatment is a new therapeutic option in this severe and recalcitrant disorder.
10
Dissecting cellulitis in a white male: response to isotretinoin
Rafet Koca, H. Cevdet Altinyazar, Özlem Özen et al. · International Journal of Dermatology · 2002 · 43 citations
Medicine, Dermatology, Pathology +11